J-code activations simplify billing reimbursements for practices

December 3, 2019
Several CMS-designated permanent and product-specific J-codes recently went into effect, allowing three ophthalmology-minded pharmaceutical companies…


BLOG: Privilege and opting out

December 2, 2019
A couple of years ago, I sat at Virginia Episcopal School in a meeting between the headmaster, Tommy Battle, and a group of parents. Mr. Battle had…

Canada recommends Verkazia reimbursement

November 25, 2019
The Canadian Drug Expert Committee has issued a reimbursement recommendation for Verkazia eye drops, a treatment for severe vernal…

Meeting NewsVideo

VIDEO: Ocular Therapeutix delivers update on Dextenza launch

November 24, 2019
NEW YORK — At the OSN New York 2019 meeting, Scott Corning, senior vice president of commercial, gives an update on the launch of Dextenza, the…

Glaukos completes Avedro acquisition

November 22, 2019
Glaukos Corporation has completed acquisition of Avedro, Inc., according to a press release. Under the terms of the all-stock transaction agreement…

ProQR’s retinitis pigmentosa treatment gets orphan drug designation

November 21, 2019
QR-1123, a first-in-class investigational antisense oligonucleotide for the treatment of vision loss associated with autosomal dominant retinitis…

Aerie expands into dry eye space with acquisition of Avizorex

November 20, 2019
Aerie Pharmaceuticals has acquired the Spanish ophthalmic pharmaceutical company Avizorex Pharma, which is developing dry eye disease treatments…

Meeting NewsVideo

VIDEO: Strategist considers pros, cons of private equity

November 17, 2019
NEW YORK — At the Open Your Eyes to Private Equity meeting preceding OSN New York 2019, Shareef Mahdavi, president of SM2 Strategic, discusses…

Meeting NewsVideo

VIDEO: ‘Arc of material’ presented at private equity meeting

November 16, 2019
NEW YORK — At the Open Your Eyes to Private Equity meeting preceding OSN New York 2019, moderator John B. Pinto discusses the inaugural event…

Meeting NewsVideo

VIDEO: ‘Window is open’ for private equity

November 15, 2019
NEW YORK — Richard L. Lindstrom, MD, discusses how private equity investments in ophthalmology could be beneficial to practice owners at the…

Meeting NewsVideo

VIDEO: Open Your Eyes to Private Equity offers information, education

November 15, 2019
NEW YORK — At the Open Your Eyes to Private Equity meeting preceding OSN New York 2019, Jim Mazzo, global president of ophthalmic devices at…

BLOG: Seven questions to ask when considering private equity

November 13, 2019
I’m heading East to participate in the Healio event “Open Your Eyes to Private Equity” as a panelist tomorrow afternoon just ahead…

ELT Sight acquires excimer laser system assets from MLase

November 13, 2019
ELT Sight has acquired the IP and assets for MLase’s excimer ophthalmic laser system for glaucoma surgery, according to a press release. The…

Guide Dog Foundation to receive training modules made from recycled contact lenses

November 13, 2019
Bausch + Lomb has partnered with TerraCycle to donate custom training modules made from recycled contact lenses to the Guide Dog Foundation…

Jiangsu Hengrui Medicine licenses Novaliq’s dry eye products in China

November 12, 2019
Jiangsu Hengrui Medicine will develop, manufacture and license NOV03 and CyclASol in China, Hong Kong, Macau and Taiwan following the closing of an…

Ocular Therapeutix announces operational restructuring

November 11, 2019
Ocular Therapeutix will restructure its operations, resulting in approximately $11 million in annualized savings, according to a press release. The…

Meeting NewsVideo

VIDEO: Norlase unveils new Leaf laser

November 10, 2019
SAN FRANCISCO — At the American Academy of Ophthalmology meeting, Oliver Hvidt, CEO and co-founder of Norlase, discusses the company’s…

Ocuphire advances Nyxol to address varied ocular indications

November 8, 2019
Ocuphire Pharma Inc. will prioritize the development of Nyxol eye drops for three indications following positive topline results from two phase 2…

Cedars-Sinai receives $10.5 million to study RP stem cell treatment

November 8, 2019
Cedars-Sinai researchers have received a $10.5 million grant from the California Institute for Regenerative Medicine to launch a clinical trial…

Meeting News

OCTANe expands reach with creation of new signature meeting

November 8, 2019
OCTANe has announced the creation of a new meeting to expand its reach with the addition of a new signature event, the organization announced in a…